お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はオルガノイド市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはオルガノイドの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のオルガノイド市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはオルガノイドのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にオルガノイド市場を分類しています。本研究に含まれる主な企業は：Thermo Fisher Scientific、Merck、Corning、STEMCELL Technologies、Lonza、Prellis Biologics、amsbio、Tanwang Medical、Ketu Medicine、Chuangxin International

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Stem Cell Source
    Tumor Cell Source

用途別の市場セグメント：
    Precision Medicine
    Pharmaceutical R&D
    Academics and Research Institutes

本レポートの詳細内容
世界のオルガノイド市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、オルガノイドタイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のオルガノイド収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のオルガノイド市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、オルガノイド市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

オルガノイドのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：オルガノイドのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：オルガノイドの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章オルガノイド企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：オルガノイドの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：オルガノイドの主要企業の概要を提供し、製品の説明と仕様、オルガノイドの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality.

The global Organoids market is projected to grow from US$ 67 million in 2024 to US$ 185 million by 2030, at a Compound Annual Growth Rate (CAGR) of 18.4% during the forecast period.
Organoids are a complex collection of cells grown in 3D culture medium that can summarize the various physiological and genomic characteristics of various tissues or organs. Organoids are micro-organs with three-dimensional structures that are cultivated in vitro using adult stem cells. They have highly similar genetic backgrounds and histological characteristics to organs in the body; they have complex structures similar to real organs and can partially simulate the physiological functions of the source tissues and organs; they simulate the endogenous environment to conduct research on tissue biology, development and regeneration, disease modeling, organ transplantation technology improvement, drug discovery/efficacy evaluation, and toxicology. Organoids refer to tissue analogs with a certain spatial structure formed by three-dimensional (3D) culture in vitro using adult stem cells or pluripotent stem cells. Although organoids are not true human organs, they can simulate real organs in structure and function, can simulate the structure and function of in vivo tissues to the greatest extent, and can be cultured stably for a long time (hence they are also called "micro-organs").
A major driver of the organoids market is the increasing demand for advanced models in drug discovery and personalized medicine. Organoids, which mimic the structure and function of real human organs, provide a more accurate representation of human biology compared to traditional cell cultures or animal models. This enables pharmaceutical companies to conduct more precise preclinical testing, reducing the time and cost of drug development. Additionally, organoids are being increasingly used in personalized medicine, where they can help tailor treatments to individual patients by predicting how they will respond to specific therapies, particularly in cancer research.
One of the main challenges in the organoids market is the complexity and high cost of organoid development and maintenance. Creating organoids that accurately replicate human organs requires sophisticated techniques and specialized equipment, making the process expensive and technically demanding. Additionally, there are still limitations in scaling up production and standardizing protocols, which hinders widespread adoption in clinical settings. Regulatory hurdles and the need for more validation studies to ensure the reliability of organoids in predicting human responses also pose barriers to market growth.
Report Includes
This report presents an overview of global market for Organoids market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Organoids, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Organoids, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Organoids revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Organoids market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Organoids revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Merck, Corning, STEMCELL Technologies, Lonza, Prellis Biologics, amsbio, Tanwang Medical, Ketu Medicine, Chuangxin International, etc.

Market Segmentation
By Company
    Thermo Fisher Scientific
    Merck
    Corning
    STEMCELL Technologies
    Lonza
    Prellis Biologics
    amsbio
    Tanwang Medical
    Ketu Medicine
    Chuangxin International

Segment by Type
    Stem Cell Source
    Tumor Cell Source

Segment by Application
    Precision Medicine
    Pharmaceutical R&D
    Academics and Research Institutes

By Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of South America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Organoids in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organoids companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Organoids revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
 Table 1. Global Organoids Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Stem Cell Source
 Table 3. Key Players of Tumor Cell Source
 Table 4. Global Organoids Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Organoids Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Organoids Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Organoids Market Share by Region (2019-2024)
 Table 8. Global Organoids Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Organoids Market Share by Region (2025-2030)
 Table 10. Organoids Market Trends
 Table 11. Organoids Market Drivers
 Table 12. Organoids Market Challenges
 Table 13. Organoids Market Restraints
 Table 14. Global Organoids Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Organoids Market Share by Players (2019-2024)
 Table 16. Global Top Organoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoids as of 2023)
 Table 17. Global Organoids Industry Ranking 2022 VS 2023
 Table 18. Global 5 Largest Players Market Share by Organoids Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Organoids, Headquarters and Area Served
 Table 20. Global Key Players of Organoids, Product and Application
 Table 21. Global Key Players of Organoids, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Organoids Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Organoids Revenue Market Share by Type (2019-2024)
 Table 25. Global Organoids Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Organoids Revenue Market Share by Type (2025-2030)
 Table 27. Global Organoids Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Organoids Revenue Market Share by Application (2019-2024)
 Table 29. Global Organoids Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Organoids Revenue Market Share by Application (2025-2030)
 Table 31. North America Organoids Market Size by Type (2019-2024) & (US$ Million)
 Table 32. North America Organoids Market Size by Type (2025-2030) & (US$ Million)
 Table 33. North America Organoids Market Size by Application (2019-2024) & (US$ Million)
 Table 34. North America Organoids Market Size by Application (2025-2030) & (US$ Million)
 Table 35. North America Organoids Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. North America Organoids Market Size by Country (2019-2024) & (US$ Million)
 Table 37. North America Organoids Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Europe Organoids Market Size by Type (2019-2024) & (US$ Million)
 Table 39. Europe Organoids Market Size by Type (2025-2030) & (US$ Million)
 Table 40. Europe Organoids Market Size by Application (2019-2024) & (US$ Million)
 Table 41. Europe Organoids Market Size by Application (2025-2030) & (US$ Million)
 Table 42. Europe Organoids Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Europe Organoids Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Europe Organoids Market Size by Country (2025-2030) & (US$ Million)
 Table 45. China Organoids Market Size by Type (2019-2024) & (US$ Million)
 Table 46. China Organoids Market Size by Type (2025-2030) & (US$ Million)
 Table 47. China Organoids Market Size by Application (2019-2024) & (US$ Million)
 Table 48. China Organoids Market Size by Application (2025-2030) & (US$ Million)
 Table 49. Asia Organoids Market Size by Type (2019-2024) & (US$ Million)
 Table 50. Asia Organoids Market Size by Type (2025-2030) & (US$ Million)
 Table 51. Asia Organoids Market Size by Application (2019-2024) & (US$ Million)
 Table 52. Asia Organoids Market Size by Application (2025-2030) & (US$ Million)
 Table 53. Asia Organoids Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 54. Asia Organoids Market Size by Region (2019-2024) & (US$ Million)
 Table 55. Asia Organoids Market Size by Region (2025-2030) & (US$ Million)
 Table 56. Middle East, Africa, and Latin America Organoids Market Size by Type (2019-2024) & (US$ Million)
 Table 57. Middle East, Africa, and Latin America Organoids Market Size by Type (2025-2030) & (US$ Million)
 Table 58. Middle East, Africa, and Latin America Organoids Market Size by Application (2019-2024) & (US$ Million)
 Table 59. Middle East, Africa, and Latin America Organoids Market Size by Application (2025-2030) & (US$ Million)
 Table 60. Middle East, Africa, and Latin America Organoids Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 61. Middle East, Africa, and Latin America Organoids Market Size by Country (2019-2024) & (US$ Million)
 Table 62. Middle East, Africa, and Latin America Organoids Market Size by Country (2025-2030) & (US$ Million)
 Table 63. Thermo Fisher Scientific Company Details
 Table 64. Thermo Fisher Scientific Business Overview
 Table 65. Thermo Fisher Scientific Organoids Product
 Table 66. Thermo Fisher Scientific Revenue in Organoids Business (2019-2024) & (US$ Million)
 Table 67. Thermo Fisher Scientific Recent Development
 Table 68. Merck Company Details
 Table 69. Merck Business Overview
 Table 70. Merck Organoids Product
 Table 71. Merck Revenue in Organoids Business (2019-2024) & (US$ Million)
 Table 72. Merck Recent Development
 Table 73. Corning Company Details
 Table 74. Corning Business Overview
 Table 75. Corning Organoids Product
 Table 76. Corning Revenue in Organoids Business (2019-2024) & (US$ Million)
 Table 77. Corning Recent Development
 Table 78. STEMCELL Technologies Company Details
 Table 79. STEMCELL Technologies Business Overview
 Table 80. STEMCELL Technologies Organoids Product
 Table 81. STEMCELL Technologies Revenue in Organoids Business (2019-2024) & (US$ Million)
 Table 82. STEMCELL Technologies Recent Development
 Table 83. Lonza Company Details
 Table 84. Lonza Business Overview
 Table 85. Lonza Organoids Product
 Table 86. Lonza Revenue in Organoids Business (2019-2024) & (US$ Million)
 Table 87. Lonza Recent Development
 Table 88. Prellis Biologics Company Details
 Table 89. Prellis Biologics Business Overview
 Table 90. Prellis Biologics Organoids Product
 Table 91. Prellis Biologics Revenue in Organoids Business (2019-2024) & (US$ Million)
 Table 92. Prellis Biologics Recent Development
 Table 93. amsbio Company Details
 Table 94. amsbio Business Overview
 Table 95. amsbio Organoids Product
 Table 96. amsbio Revenue in Organoids Business (2019-2024) & (US$ Million)
 Table 97. amsbio Recent Development
 Table 98. Tanwang Medical Company Details
 Table 99. Tanwang Medical Business Overview
 Table 100. Tanwang Medical Organoids Product
 Table 101. Tanwang Medical Revenue in Organoids Business (2019-2024) & (US$ Million)
 Table 102. Tanwang Medical Recent Development
 Table 103. Ketu Medicine Company Details
 Table 104. Ketu Medicine Business Overview
 Table 105. Ketu Medicine Organoids Product
 Table 106. Ketu Medicine Revenue in Organoids Business (2019-2024) & (US$ Million)
 Table 107. Ketu Medicine Recent Development
 Table 108. Chuangxin International Company Details
 Table 109. Chuangxin International Business Overview
 Table 110. Chuangxin International Organoids Product
 Table 111. Chuangxin International Revenue in Organoids Business (2019-2024) & (US$ Million)
 Table 112. Chuangxin International Recent Development
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Organoids Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 2. Global Organoids Market Share by Type: 2023 VS 2030
 Figure 3. Stem Cell Source Features
 Figure 4. Tumor Cell Source Features
 Figure 5. Global Organoids Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 6. Global Organoids Market Share by Application: 2023 VS 2030
 Figure 7. Precision Medicine Case Studies
 Figure 8. Pharmaceutical R&D Case Studies
 Figure 9. Academics and Research Institutes Case Studies
 Figure 10. Organoids Report Years Considered
 Figure 11. Global Organoids Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 12. Global Organoids Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Organoids Market Share by Region: 2023 VS 2030
 Figure 14. Global Organoids Market Share by Players in 2023
 Figure 15. Global Top Organoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoids as of 2023)
 Figure 16. The Top 10 and 5 Players Market Share by Organoids Revenue in 2023
 Figure 17. North America Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 18. North America Organoids Market Share by Type (2019-2030)
 Figure 19. North America Organoids Market Share by Application (2019-2030)
 Figure 20. North America Organoids Market Share by Country (2019-2030)
 Figure 21. United States Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Organoids Market Share by Type (2019-2030)
 Figure 25. Europe Organoids Market Share by Application (2019-2030)
 Figure 26. Europe Organoids Market Share by Country (2019-2030)
 Figure 27. Germany Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. France Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. U.K. Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Italy Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Russia Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Nordic Countries Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. China Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. China Organoids Market Share by Type (2019-2030)
 Figure 35. China Organoids Market Share by Application (2019-2030)
 Figure 36. Asia Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Asia Organoids Market Share by Type (2019-2030)
 Figure 38. Asia Organoids Market Share by Application (2019-2030)
 Figure 39. Asia Organoids Market Share by Region (2019-2030)
 Figure 40. Japan Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. South Korea Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. India Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Australia Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East, Africa, and Latin America Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Middle East, Africa, and Latin America Organoids Market Share by Type (2019-2030)
 Figure 48. Middle East, Africa, and Latin America Organoids Market Share by Application (2019-2030)
 Figure 49. Middle East, Africa, and Latin America Organoids Market Share by Country (2019-2030)
 Figure 50. Brazil Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. Mexico Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 52. Turkey Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 53. Saudi Arabia Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 54. Israel Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 55. GCC Countries Organoids Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Organoids Business (2019-2024)
 Figure 57. Merck Revenue Growth Rate in Organoids Business (2019-2024)
 Figure 58. Corning Revenue Growth Rate in Organoids Business (2019-2024)
 Figure 59. STEMCELL Technologies Revenue Growth Rate in Organoids Business (2019-2024)
 Figure 60. Lonza Revenue Growth Rate in Organoids Business (2019-2024)
 Figure 61. Prellis Biologics Revenue Growth Rate in Organoids Business (2019-2024)
 Figure 62. amsbio Revenue Growth Rate in Organoids Business (2019-2024)
 Figure 63. Tanwang Medical Revenue Growth Rate in Organoids Business (2019-2024)
 Figure 64. Ketu Medicine Revenue Growth Rate in Organoids Business (2019-2024)
 Figure 65. Chuangxin International Revenue Growth Rate in Organoids Business (2019-2024)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed